A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples